Follow-up after therapy for prostate cancer: Treating the problems and caring for the man

Postgraduate Medicine

Volumn 100, Issue 3, 1996, Pages 125-136

  Freedman, Alan ^a   Hahn, Gordon ^a   Love, Neil ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

BEAM THERAPY; CANCER RECURRENCE; CANCER RISK; CANCER SCREENING; CONFERENCE PAPER; COUNSELING; FOLLOW UP; HEALTH PROMOTION; HUMAN; IMPOTENCE; MALE; PATIENT CARE; PATIENT EDUCATION; PROSTATE CANCER; QUALITY OF LIFE; URINE INCONTINENCE;

EID: 0029786787     PISSN: 00325481     EISSN: None     Source Type: Journal    
DOI: 10.3810/pgm.1996.09.73     Document Type: Conference Paper

References (18)

1. Abi-Aad AS, Macfarlane MT, Stein A, et al. Detection of local recurrence after radical prostatectomy by prostate specific antigen and transrectal ultrasound. J Urol 1992;147(3 Pt 2):952-5
2. Burgio KL, Stutzman RE, Engel BT. Behavioral training for post-prostatectomy urinary incontinence. J Urol 1989;141(2):303-6
3. Catalona WJ, Basler JW. Return of erections and urinary continence following nerve sparing radical retropubic prostatectomy. J Urol 1993; 150(3):905-7
4. Crook J, Robertson S, Collin G, et al. Clinical relevance of trans-rectal ultrasound, biopsy, and serum prostate-specific antigen following external beam radiotherapy for carcinoma of the prostate. Int J Radiat Oncol Biol Phys 1993;27(1):31-7
5. Fijuth J, Chauvet B, Vincent P, et al. Serum prostate-specific antigen in monitoring the response of carcinoma of the prostate to radiation therapy. Radiother Oncol 1992;23(4):236-4
6. Foster LS, Jajodia P, Fournier G Jr, et al. The value of prostate specific antigen and transrectal ultrasound guided biopsy in detecting prostatic fossa recurrences following radical prostatectomy. J Urol 1993;149(5): 1024-8
7. Goad JR, Chang SJ, Ohori M, et al. PSA after definitive radiotherapy for clinically localized prostate cancer. Urol Clin North Am 1993;20(4): 727-36
8. Leach GE, Yun SK. Post-prostatectomy incontinence. II. The results of treatment based on urodynamic evaluation. Neurourol Urodynam 1992; 11:99-105
9. Leach GE, Yun SK. Post-prostatectomy incontinence: I. The urodynamic findings in 107 men. Neurourol Urodynam 1992;11:91-7
10. Lightner DJ, Lange PH, Reddy PK, et al. Prostate specific antigen and local recurrence after radical prostatectomy. J Urol 1990;144(4): 921-6
11. Miller PD, Eardley I, Kirby RS. Prostate specific antigen and bone scan correlation in the staging and monitoring of patients with prostatic cancer. Br J Urol 1992;70(3):295-8
12. Oesterling JE, Chan DW, Epstein JI, et al. Prostate specific antigen in the preoperative and postoperative evaluation of localized prostatic cancer treated with radical prostatectomy. J Urol 1988;139(4):766-72
13. Partin AW, Pound CR, Clemens JQ, et al. Serum PSA after anatomic radical prostatectomy: the Johns Hopkins experience after 10 years. Urol Clin North Am 1993;20(4):713-25
14. Quinlan DM, Epstein JI, Carter BS, et al. Sexual function following radical prostatectomy: influence of preservation of neurovascular bundles. J Urol 1991;145(5):998-1002
15. Schover LR. Sexual rehabilitation after treatment for prostate cancer. Cancer 1993;71(3 Suppl):1024-30
16. Singer PA, Tasch ES, Stocking C, et al. Sex or survival: trade-offs between quality and quantity of life. J Clin Oncol 1991;9(2):328-34
17. Stein A, deKernion JB, Dorey F. Prostatic specific antigen related to clinical status 1 to 14 years after radical retropubic prostatectomy. Br J Urol 1991;67(6):626-31
18. Steiner MS, Morton RA, Walsh PC. Impact of anatomical radical prostatectomy on urinary continence. J Urol 1991;145(3):512-5